Uterine Mesenchymal Tumors: Hereditary Aspects

Area of Science:

• Gynecologic Oncology
• Pathology
• Genetics

Background:

• Hereditary gynecologic malignancies are often linked to Lynch syndrome (endometrial adenocarcinoma) and BRCA mutations (tubo-ovarian serous carcinoma).
• Familial associations with uterine mesenchymal tumors are less commonly recognized.
• Two primary hereditary syndromes linked to uterine mesenchymal tumors are hereditary leiomyomatosis and renal cell carcinoma syndrome and tuberous sclerosis complex.

Purpose of the Study:

• To review the current literature on hereditary syndromes associated with uterine mesenchymal tumors.
• To summarize clinical, morphologic, immunophenotypic, and genetic data for these syndromes.
• To emphasize the diagnostic significance of surgical pathology in identifying potential familial cancer syndromes.

Main Methods:

• Literature review of current research on hereditary leiomyomatosis and renal cell carcinoma syndrome and tuberous sclerosis complex.
• Synthesis of clinical, morphologic, immunophenotypic, and genetic findings.
• Emphasis on the role of surgical pathology in diagnosis.

Main Results:

• Hereditary leiomyomatosis and renal cell carcinoma syndrome and tuberous sclerosis complex are significant hereditary causes of uterine mesenchymal tumors.
• Detailed clinical, morphologic, immunophenotypic, and genetic characteristics of these syndromes are presented.
• Surgical pathologic diagnosis can be an early indicator of these underlying familial syndromes.

Conclusions:

• Pathologists' familiarity with suggestive lesions is vital for early detection of hereditary gynecologic cancer syndromes.
• Recognition of these syndromes impacts patient management and genetic counseling.
• Further research into less common familial gynecologic malignancies is warranted.